DK0789709T3 - Peptidspecificitet af anti-myelin basisprotein og administrationen af myelin basisproteinpeptider til dissemineret sklerose patienter - Google Patents
Peptidspecificitet af anti-myelin basisprotein og administrationen af myelin basisproteinpeptider til dissemineret sklerose patienterInfo
- Publication number
- DK0789709T3 DK0789709T3 DK95934017T DK95934017T DK0789709T3 DK 0789709 T3 DK0789709 T3 DK 0789709T3 DK 95934017 T DK95934017 T DK 95934017T DK 95934017 T DK95934017 T DK 95934017T DK 0789709 T3 DK0789709 T3 DK 0789709T3
- Authority
- DK
- Denmark
- Prior art keywords
- mbp
- myelin basic
- basic protein
- administration
- residues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/327,357 US5817629A (en) | 1991-10-22 | 1994-10-21 | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| PCT/CA1995/000583 WO1996012731A1 (en) | 1994-10-21 | 1995-10-20 | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0789709T3 true DK0789709T3 (da) | 2001-09-10 |
Family
ID=23276218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95934017T DK0789709T3 (da) | 1994-10-21 | 1995-10-20 | Peptidspecificitet af anti-myelin basisprotein og administrationen af myelin basisproteinpeptider til dissemineret sklerose patienter |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5817629A (da) |
| EP (1) | EP0789709B1 (da) |
| AT (1) | ATE201415T1 (da) |
| AU (1) | AU713546B2 (da) |
| CA (1) | CA2203018A1 (da) |
| CZ (1) | CZ292454B6 (da) |
| DE (1) | DE69521055T2 (da) |
| DK (1) | DK0789709T3 (da) |
| ES (1) | ES2159322T3 (da) |
| FI (1) | FI120308B (da) |
| HU (1) | HU217633B (da) |
| NO (1) | NO321385B1 (da) |
| NZ (1) | NZ293910A (da) |
| PL (1) | PL182508B1 (da) |
| RO (1) | RO117096B1 (da) |
| RU (1) | RU2157815C2 (da) |
| SK (1) | SK282463B6 (da) |
| UA (1) | UA55375C2 (da) |
| WO (1) | WO1996012731A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6252040B1 (en) * | 1991-10-22 | 2001-06-26 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| US20020111312A1 (en) * | 1991-10-22 | 2002-08-15 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| US6251396B1 (en) * | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| US6329499B1 (en) | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
| CA2494338C (en) * | 1997-04-04 | 2007-07-17 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| US20030191063A1 (en) * | 2000-08-21 | 2003-10-09 | Wraith David Cameron | Peptide selection method |
| IL142536A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Carriers for therapeutic preparations for treatment of t-cell mediated diseases |
| IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
| US7560529B2 (en) | 2001-04-24 | 2009-07-14 | FDS Pharma | Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| RU2221873C2 (ru) * | 2001-04-24 | 2004-01-20 | Закрытое акционерное общество "АСГЛ-Фармацевтические Инновации" | Способ получения каталитических антител (варианты), антигены для иммунизации и нуклеотидная последовательность |
| EP1390497A2 (en) | 2001-05-25 | 2004-02-25 | Genset | Human cdnas and proteins and uses thereof |
| NZ539106A (en) * | 2002-10-10 | 2007-02-23 | Yeda Res & Dev | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| WO2004073625A2 (en) * | 2003-02-14 | 2004-09-02 | Provid Pharmaceuticals, Inc. | Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| EP2117301A4 (en) * | 2007-02-26 | 2010-04-14 | Yeda Res & Dev | USE OF LONG-CHAINED ALCOHOL DERIVATIVES FOR THE TREATMENT OF CIRCULAR HAIR LOSS |
| US7964751B2 (en) * | 2007-02-26 | 2011-06-21 | Yeda Research And Development Co. Ltd. | Enantiomers of amino-phenyl-acetic acid octadec-9-(Z) enyl ester, their salts and their uses |
| AU2008320657B2 (en) | 2007-10-31 | 2013-09-05 | Worg Pharmaceuticals (Zhejiang) Co., Ltd. | Composition |
| AU2008331789A1 (en) * | 2007-12-03 | 2009-06-11 | Provid Pharmaceuticals, Inc. | Inhibitors of antigen presentation by MHC Class II molecules and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2512796B2 (ja) | 1987-06-24 | 1996-07-03 | オートイミュン・インコーポレイテッド | 自己抗原の経口投与による自己免疫疾患の治療法 |
| US6039947A (en) | 1987-06-24 | 2000-03-21 | Autoimmune, Inc. | Peptides derived from immunodominant epitopes of myelin basic protein |
| US5571499A (en) | 1987-06-24 | 1996-11-05 | Autoimmune, Inc. | Treatment of autoimmune diseases by aerosol administration of autoantigens |
| US5571500A (en) | 1987-06-24 | 1996-11-05 | Autoimmune, Inc. | Treatment of autoimmune diseases through administration by inhalation of autoantigens |
| US5645820A (en) | 1987-06-24 | 1997-07-08 | Autoimmune, Inc. | Treatment of autoimmune diseases by aerosol administration of autoantigens |
| US5641474A (en) | 1987-06-24 | 1997-06-24 | Autoimmune, Inc. | Prevention of autoimmune diseases by aerosol administration of autoantigens |
| US5869054A (en) | 1987-06-24 | 1999-02-09 | Autoimmune Inc. | Treatment of multiple sclerosis by oral administration of autoantigens |
| US5849298A (en) | 1987-06-24 | 1998-12-15 | Autoimmune Inc. | Treatment of multiple sclerosis by oral administration of bovine myelin |
| CA1340012C (en) * | 1987-08-17 | 1998-08-25 | Trustees Of Leland Stanford Jr. University | Peptide determinant associated with immunity |
| IL165071A (en) | 1990-03-30 | 2008-06-05 | Autoimmune Inc | A peptide with the ability to stimulate a subset of T cells from multiple sclerosis patients |
| US5858980A (en) | 1990-03-30 | 1999-01-12 | Autoimmune, Inc. | Peptide fragments of myelin basic protein |
| CA2053799C (en) * | 1991-10-22 | 2002-03-12 | Kenneth G. Warren | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| ES2172044T3 (es) * | 1992-04-09 | 2002-09-16 | Autoimmune Inc | Supresion de la proliferacion de celulas t usando fragmentos peptidicos de proteina basica de mielina. |
| WO1996028470A2 (en) | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis |
| US5935577A (en) | 1998-01-23 | 1999-08-10 | Autoimmune Inc. | Treatment of autoimmune disease using tolerization in combination with methotrexate |
-
1994
- 1994-10-21 US US08/327,357 patent/US5817629A/en not_active Expired - Lifetime
-
1995
- 1995-10-20 UA UA97052322A patent/UA55375C2/uk unknown
- 1995-10-20 RO RO97-00769A patent/RO117096B1/ro unknown
- 1995-10-20 PL PL95319835A patent/PL182508B1/pl not_active IP Right Cessation
- 1995-10-20 DK DK95934017T patent/DK0789709T3/da active
- 1995-10-20 AU AU36478/95A patent/AU713546B2/en not_active Ceased
- 1995-10-20 CA CA002203018A patent/CA2203018A1/en not_active Abandoned
- 1995-10-20 HU HU9701679A patent/HU217633B/hu not_active IP Right Cessation
- 1995-10-20 ES ES95934017T patent/ES2159322T3/es not_active Expired - Lifetime
- 1995-10-20 WO PCT/CA1995/000583 patent/WO1996012731A1/en active IP Right Grant
- 1995-10-20 AT AT95934017T patent/ATE201415T1/de not_active IP Right Cessation
- 1995-10-20 DE DE69521055T patent/DE69521055T2/de not_active Expired - Lifetime
- 1995-10-20 NZ NZ293910A patent/NZ293910A/xx not_active IP Right Cessation
- 1995-10-20 EP EP95934017A patent/EP0789709B1/en not_active Expired - Lifetime
- 1995-10-20 SK SK492-97A patent/SK282463B6/sk not_active IP Right Cessation
- 1995-10-20 RU RU97107853/04A patent/RU2157815C2/ru not_active IP Right Cessation
- 1995-10-20 CZ CZ19971169A patent/CZ292454B6/cs not_active IP Right Cessation
-
1997
- 1997-04-18 FI FI971662A patent/FI120308B/fi active IP Right Grant
- 1997-04-21 NO NO19971829A patent/NO321385B1/no not_active IP Right Cessation
-
1998
- 1998-01-15 US US09/007,520 patent/US6258781B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6258781B1 (en) | 2001-07-10 |
| AU3647895A (en) | 1996-05-15 |
| SK49297A3 (en) | 1997-11-05 |
| UA55375C2 (uk) | 2003-04-15 |
| PL319835A1 (en) | 1997-09-01 |
| CA2203018A1 (en) | 1996-05-02 |
| DE69521055D1 (de) | 2001-06-28 |
| AU713546B2 (en) | 1999-12-02 |
| RU2157815C2 (ru) | 2000-10-20 |
| FI971662A0 (fi) | 1997-04-18 |
| PL182508B1 (pl) | 2002-01-31 |
| FI971662A (fi) | 1997-06-17 |
| ATE201415T1 (de) | 2001-06-15 |
| FI120308B (fi) | 2009-09-15 |
| HUT76977A (hu) | 1998-01-28 |
| CZ116997A3 (en) | 1997-10-15 |
| ES2159322T3 (es) | 2001-10-01 |
| HU217633B (hu) | 2000-03-28 |
| US5817629A (en) | 1998-10-06 |
| NO321385B1 (no) | 2006-05-02 |
| RO117096B1 (ro) | 2001-10-30 |
| NO971829L (no) | 1997-06-23 |
| EP0789709B1 (en) | 2001-05-23 |
| SK282463B6 (sk) | 2002-02-05 |
| DE69521055T2 (de) | 2001-11-22 |
| WO1996012731A1 (en) | 1996-05-02 |
| NZ293910A (en) | 1999-07-29 |
| NO971829D0 (no) | 1997-04-21 |
| CZ292454B6 (cs) | 2003-09-17 |
| EP0789709A1 (en) | 1997-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0789709T3 (da) | Peptidspecificitet af anti-myelin basisprotein og administrationen af myelin basisproteinpeptider til dissemineret sklerose patienter | |
| DE69334266D1 (de) | Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate | |
| ATE415173T1 (de) | Pan dr-bindeproteinen zur erhöhung der immunantwort | |
| HK1010983A1 (en) | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products | |
| KR980002066A (ko) | 변이형 인간 성장호르몬 및 그의 용도 | |
| FI941860A0 (fi) | Keskushermoston pesäkekovettumatautiaivo-selkäydinnesteestä peräisin olevan antimyeliiniemäsproteiinin synteettinen peptidispesifisyys | |
| CY1108239T1 (el) | Θραυσματα πεπτιδιου της βασικης πρωτεϊνης της μυελινης, οι φαρμακευτικες τους συνθεσεις και η χρηση τους στη θεραπεια της σκληρυνσης κατα πλακας | |
| WO1996018646A3 (en) | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease | |
| WO1995030435A3 (en) | Compositions and treatment for multiple sclerosis | |
| NZ335835A (en) | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |